Research & KnowledgeEvent: August 31, 2026
Renew Biotechnologies identified distinct neuron-associated cfDNA patterns across neurodegenerative diseases, including elevated cortical neuron-like signals in Alzheimer’s disease, dopaminergic neuron-like signals in Parkinson’s disease, and spinal motor neuron-like signals in ALS.
Published
Signal category
Research & Knowledge
Quote
“Our recent work identified distinct neuron-associated cfDNA patterns across neurodegenerative diseases, including elevated cortical neuron-like signals in Alzheimer’s disease, dopaminergic neuron-like signals in Parkinson’s disease, and spinal motor neuron-like signals in ALS.”
— Renew Biotechnologies team
Company
- Industry
- Biotechnology Research
- Location
- Pleasant Grove, US
- Company size
- 20 employees
Renew Biotechnologies develops genomic and epigenomic technologies purpose-built for clinical translation—bridging the gap between breakthrough discovery and diagnostic impact.
Founded 2022